Great news Jen mentioned 1 of the patients who survived +14 months in the CHM1101 trial is still alive. The phase 1a data webinar was 23/10/2023, so that patient is still alive after 18.5 months which is outstanding.
https://www.forbes.com/sites/forbeseq/2024/03/01/the-white-house-war-on-glioblastoma/?sh=6c434a9551ae
Glioblastoma is close to the White houses heart, Joe Biden lost a son to this horrendous illness.
On another note it'll be a month this Friday since the 1st patient was treated in the ADVENT-AML trial. I wonder if we'll get some safety news shortly after.
Great news Jen mentioned 1 of the patients who survived +14...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $27.11K | 6.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 25563938 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 2764371 | 3 |
View Market Depth
| Last trade - 11.20am 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |